Eli Lilly And Stock Minimum Initial Investment
LLY Stock | MXN 16,063 5.95 0.04% |
Eli Lilly and fundamentals help investors to digest information that contributes to Eli Lilly's financial success or failures. It also enables traders to predict the movement of Eli Stock. The fundamental analysis module provides a way to measure Eli Lilly's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eli Lilly stock.
Eli |
Eli Lilly and Company Minimum Initial Investment Analysis
Eli Lilly's Minimum Initial Investment refers to minimum amount the fund family or category will require an investor to deposit to acquire the very first position in the fund or to open an account. In other words, Minimum Initial Investment is a guarantee that any investment from a purchaser of a fund meets the minimum requirement of the fund.
More About Minimum Initial Investment | All Equity Analysis
Minimum Initial Investment | = | First Fund Deposit |
Fund managers put minimum investment restrictions on fund investments in order to allow the fund to function properly. Minimum restrictions allow fund managers to regulate cash flows of the fund, while guarding it against random trades that may negatively affect fund strategy.
Competition |
Based on the recorded statements, Eli Lilly and has a Minimum Initial Investment of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers - Major (which currently averages 0.0) industry. This indicator is about the same for all Mexico stocks average (which is currently at 0.0).
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
All Next | Launch Module |
Eli Fundamentals
Return On Equity | 0.65 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.29 % | |||
Current Valuation | 6.99 T | |||
Shares Outstanding | 950.18 M | |||
Shares Owned By Insiders | 0.15 % | |||
Shares Owned By Institutions | 85.00 % | |||
Price To Earning | 333.06 X | |||
Price To Book | 34.76 X | |||
Price To Sales | 231.96 X | |||
Revenue | 28.54 B | |||
Gross Profit | 21.91 B | |||
EBITDA | 8.28 B | |||
Net Income | 6.24 B | |||
Cash And Equivalents | 2.2 B | |||
Cash Per Share | 2.39 X | |||
Total Debt | 15.35 B | |||
Debt To Equity | 648.20 % | |||
Current Ratio | 1.12 X | |||
Book Value Per Share | 11.19 X | |||
Cash Flow From Operations | 7.26 B | |||
Earnings Per Share | 123.49 X | |||
Price To Earnings To Growth | 2.23 X | |||
Number Of Employees | 47 | |||
Beta | 0.35 | |||
Market Capitalization | 6.16 T | |||
Total Asset | 48.81 B | |||
Annual Yield | 0.01 % | |||
Five Year Return | 2.46 % | |||
Net Asset | 48.81 B | |||
Last Dividend Paid | 3.92 |
About Eli Lilly Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eli Lilly and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eli Lilly using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eli Lilly and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.